Airfinity has downgraded its global sales forecast for COVID-19 vaccines this year from $80.8bn to $64.1bn.
Analysis of vaccine production, deliveries, supply deals and doses administered shows demand is falling and with it vaccine sales. Vaccination rates around the world have rapidly dropped since the start of 2022.
Airfinity forecasts annual demand to be 6 billion doses this year, falling to between 2-4 billion in 2023 and beyond. Fill out the form to receive the full forecast report.
For press enquiries, please contact firstname.lastname@example.org